Evidence map›Paper›PMID 37539573›Full record

ArticleZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2023

Characteristics of Gram-positive cocci infection and the therapeutic effect after liver transplantation.

Xiaoxia Wu, Lingli Wu, Lin Shu, Chenpeng Xie, Qiquan Wan

Open access · greenAbstract read
In one paragraph

Article in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Xiaoxia WuNursing Department, Third Xiangya Hospital, Central South University, Changsha 410013. 171970473@qq.com.
Lingli WuXiangya School of Nursing, Central South University, Changsha 410013.
Lin ShuXiangya School of Nursing, Central South University, Changsha 410013.
Chenpeng XieXiangya School of Nursing, Central South University, Changsha 410013.
Qiquan WanTransplantation Center, Third Xiangya Hospital, Central South University, Changsha 410013, China. 13548685542@163.com.
Central South University · CN

Funding

the China International Medical Foundation Special Fund for Young and Middle-aged Medical Research Z-2018-35-2003
6 · The paper itself

Abstract

objectivesGram-positive cocci is the main pathogen responsible for early infection after liver transplantation (LT), posing a huge threat to the prognosis of liver transplant recipients. This study aims to analyze the distribution and drug resistance of Gram-positive cocci, the risk factors for infections and efficacy of antibiotics within 2 months after LT, and to guide the prevention and treatment of these infections.

methodsIn this study, data of pathogenic bacteria distribution, drug resistance and therapeutic efficacy were collected from 39 Gram-positive cocci infections among 256 patients who received liver transplantation from donation after citizens' death in the Third Xiangya Hospital of Central South University from January 2019 to July 2022, and risk factors for Gram-positive cocci infection were analyzed.

results

conclusionsGram-positive cocci infections occurring early after liver transplantation were dominated by

Indexed as

DaptomycinEnd Stage Liver DiseaseGram-Positive Bacterial InfectionsGram-Positive CocciLiver TransplantationAnti-Bacterial AgentsHumansLinezolidMicrobial Sensitivity TestsSeverity of Illness IndexTeicoplaninTigecyclineVancomycinAnti-Bacterial AgentsDaptomycinLinezolidTeicoplaninTigecyclineVancomycindrug resistanceGram-positive cocci infectionliver transplantationprevention and controlrisk factors

Identifiers

PMID37539573
PMCPMC10930403
OpenAlexW4385564731

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.